Abstract
Objective
To evaluate the impact of administration context (embedded versus stand-alone) on the reliability and validity of the FACT Head and Neck Symptom Index (FHNSI).
Methods
Ninety-eight patients with head and neck cancer were randomized to one of two assessment conditions to evaluate the FHNSI’s context (items administered embedded within the FACT-H&N or as stand-alone scale) and order of administration in the battery.
Results
Planned comparisons on the item and scale levels revealed no systematic order or context differences. The embedded and stand-alone versions of the FHNSI showed high internal consistency (Cronbach's alpha 0.79–0.87). Correlations were high between the FHNSI versions and the physical and functional well-being scales of the FACT-H&N (0.70–0.84) and measures of pain intensity (−0.73, −0.74) and depression (−0.71, −0.74); moderate to large with the Performance Status Scale for Head and Neck subscales (PSS-HN; 0.46–0.71); and low with an anxiety measure (0.30, 0.34). Both FHNSI versions differentiated patients grouped by performance status (p < .0001, p < .0001) and global rating of change (p < .0001, p < 0.01). The FHNSI's minimally important difference range was 3–4 points.
Conclusion
The FHNSI is a reliable and valid symptom index, which can be administered alone or scored using items embedded within the FACT-H&N.
Similar content being viewed by others
Abbreviations
- HRQL:
-
Health-related quality of life
- FACT-G:
-
Functional Assessment of Cancer Therapy-General
- EORTC:
-
European Organization for Research and Treatment of Cancer
- FACT-H & N:
-
FACT-Head and Neck
- FHNSI:
-
FACT Head and Neck Symptom Index
- KPS:
-
Karnofsky Performance Score
- ECOG PSR:
-
Eastern Cooperative Oncology Group Performance Status Rating
- PWB:
-
Physical well-being
- SWB:
-
Social/family well-being
- EWB:
-
Emotional well-being
- FWB:
-
Functional well-being
- HNCS:
-
Head and Neck Cancer Subscale
- PSS-HN:
-
Performance Status Scale for Head and Neck
- BPI:
-
Brief Pain Inventory
- CES-D:
-
Center for Epidemiological Studies-Depression Scale
- HADS-A:
-
Anxiety and Depression Scale-Anxiety Component
- MCSDS:
-
Marlowe–Crowne Social Desirability Scale
- GRCS:
-
Global Rating of Change Scale
- MIDs:
-
Minimally Important Differences
- SEM:
-
Standard error of measurement
References
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Lloyd, S., Linn, E., et al. (1993). The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570–579.
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984). Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation. Journal of Clinical Oncology, 2, 472–483.
Taylor, K. M., Macdonald, K. G., Bezak, A., Ng, P., & DePetrillo, A. D. (1996). Physicians’ perspective on quality of life: An exploratory study of oncologists. Quality of Life Research, 5, 5–14.
Morris, J., Perez, D., & McNoe, B. (1998). The use of quality of life data in clinical practice. Quality of Life Research, 7, 85–91.
Browman, G. P. (1999). Science, language, intuition, and the many meanings of quality of life. Journal of Clinical Oncology, 17, 1651–1653.
Gill, T. M., & Feinstein, A. R. (1994). A critical appraisal of the quality of quality-of-life measurements. Journal of the American Medical Association, 272, 619–626.
List, M. A., Ritter-Sterr, C. A., Baker, T. M., et al. (1996). Longitudinal assessment of quality of life in laryngeal cancer patients. Head & Neck, 18, 1–10.
Bjordal, K., Kaasa, S., & Mastekaasa, A. (1994). Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 28, 847–856.
Shaha, A. R., & Strong, E. W. (1995). Cancer of the head and neck. In G. P. Murphy, W. Lawrence, & R. E. Lenhard (Eds.), Clinical oncology (2nd ed., pp. 251–268). Atlanta, GA: The American Cancer Society, Inc.
Vokes, E. E., Kies, M. S., Haraf, D. J., Stenson, K., List, M. A., Humerickhouse, R., et al. (2000). Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. Journal of Clinical Oncology, 18, 1652–1661.
Cella, D., Paul, D., Yount, S., Winn, R., Chang, C. H., Banik, et al. (2003). What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Investigation, 4, 526–535.
Leidy, N. K., Legro, M., Schmier, J., et al. (2000). Does order of administration affect subject response to generic and condition-specific measures of health related quality of life? Quality of Life Research, 9, 337.
Cheung, Y.-B., Wong, L.-C., Tay, M.-H., Toh, C.-K., Koo, W.-H., Epstein, R., et al. (2004). Order effects in the assessment of quality of life in cancer patients. Quality of Life Research, 13, 1217–1223.
Cheung, Y.-B., Lim, C., Goh, C., Thumboo, J., & Wee, J. (2005). Order effects: A randomized study of three major cancer-specific quality of life instruments. Health and Quality of Life Outcomes, 3, 37.
Karnofsky, D. A., & Burchenal, J. H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In C. M. Macleod (Ed.), Evaluation of chemotherapeutic agents (pp. 199–205). New York: Columbia University Press.
Zubrod, C., Schneiderman, M., Frei, E., III, Brindley, C., Gold, G. L., Shnider, B., et al. (1960). Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene. Journal of Chronic Diseases, 11, 7–33.
List, M. A., D’Antonio, L. L., Cella, D. F., Siston, A., Mumby, P., Haraf, D., et al. (1996). The Performance Status Scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer, 77, 2294–2301.
Rogers, S. N., Courneya, K. S., Robins, K. T., Malone, J., Seiz, A., Koch, L., et al. (2006). Physical activity and quality of life in head and neck cancer survivors. Supportive Care in Cancer, 14, 1012–1019.
Epstein, J. B., Beaumont, J. L., Gwede, C. K., Murphy, B., Garden, A. S., Meredith, R., et al. (2007). Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer, 109, 1914–1922.
Smith, G. I., Yeo, D., Clark, J., Choy, E. T., Gao, K., Oates, J., et al. (2006). Measures of health-related quality of life and functional status in survivors of oral cavity cancer who have had defects reconstructed with radial forearm free flaps. British Journal of Oral & Maxillofacial Surgery, 44, 187–192.
Ringash, J., Bezjak, A., O’Sullivan, B., & Redelmeier, D. A. (2004). Interpreting differences in quality of life: The FACT-H & N in laryngeal cancer patients. Quality of Life Research, 13, 725–733.
List, M. A., Ritter-Sterr, C., & Lansky, S. B. (1990). A performance status scale for head and neck cancer patients. Cancer, 66, 564–569.
Fung, K., Teknos, T. N., Vandenberg, C. D., Lyden, T. H., Bradford, C. R., & Hogikyan, N. D. (2007). Prevention of wound complications following salvage laryngectomy using free vascularized tissue. Head & Neck, 29, 425–430.
Meyer, T. K., Kuhn, J. C., Campbell, B. H., Marbella, A. M., Myers, K. B., Layde, P. M., et al. (2004). Speech intelligibility and quality of life in head and neck cancer survivors. Laryngoscope, 114, 1977–1981.
Campbell, B. H., Spinelli, K., Marbella, A. M., Myers, K. B., Kuhn, J. C., & Layde, P. M. (2004). Aspiration, weight loss, and quality of life in head and neck cancer survivors. Archives of Otolaryngology—Head & Neck Surgery, 130, 1100–1103.
Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: Global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore, 23, 129–138.
Passik, S. D., Kirsch, K. L., Donaghy, K. B., & Portenoy, R. K. (2006). Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. The Clinical Journal of Pain, 22, 173–181.
McQuellon, R. P., Thaler, H. T., Cella, D., & Moore, D. H. (2006). Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: A Gynecologic Oncology Group study. Gynecologic Oncology, 101, 296–304.
Miaskowski, C., Dodd, M., West, C., Paul, S. M., Schumacher, K., Tripathy, D., et al. (2007). The use of responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain, 129, 55–63.
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
Rogers, S. N., Rajlawat, B., Goru, J., Lowe, D., & Humphris, G. M. (2006). Comparison of the domains of anxiety and mood of the University of Washington head and neck cancer questionnaire (UW-QOL-4) with the CES-D and HADS. Head & Neck, 28, 697–704.
Katz, M. R., Kopek, N., Waldron, J., Devins, G. M., & Tomlinson, G. (2004). Screening for depression in head and neck cancer. Psycho-Oncology, 13, 269–280.
Derks, W., Leeuy, J. R. J., Hordijk, G. J., & Winnubst, J. A. M. (2005). Differences in coping style and locus of control between older and younger patients with head and neck cancer. Clinical Otolaryngology, 30, 186–192.
List, M. A., Mumby, P., Haraf, D., Siston, A., Mick, R., MacCracken, E., et al. (1997). Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Quality of Life Research, 6, 273–284.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.
Hammerlid, E., Ahlner-Elmqvist, M., Bjordal, K., Biorklund, A., Evensen, J., Boysen, M., et al. (1999). A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. British Journal of Cancer, 80, 766–774.
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., et al. (2000). Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer, 88, 2817–2823.
Crowne, D. P., & Marlowe, D. (1960). A new scale of social desirability independent of psychopathology. Journal of Consulting Psychology, 24, 349–354.
Jaeschke, R., Singer, J., & Guyatt, G. (1989). Measurement of health status: Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407–415.
Cella, D., Yount, S., Du, H., Dhanda, R., Gondek, K., Langefeld, K., et al. (2006). Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). The Journal of Supportive Oncology, 4, 191–199.
Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Quality of Life Research, 11, 207–221.
Doyle, C., Crump, M., Pintilie, M., & Oza, A. M. (2001). Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. Journal of Clinical Oncology, 19, 1266–1274.
Serdula, M. K., Mokdad, A. H., Pamuk, E. R., Williamson, D. F., & Byers, T. (1995). Effects of question order on estimates of the prevalence of attempted weight loss. American Journal of Epidemiology, 42, 64–67.
Jensen, P. S., Watanabe, H. K., & Richters, J. E. (1999). Who’s up first? Testing for order effects in structured interviews using a counterbalanced experimental design. Journal of Abnormal Child Psychology, 27, 436–439.
Bowling, A. (2005). Mode of questionnaire administration can have serious effects on data quality. Journal of Public Health, 27, 281–291.
Ingham, J. M., & Portenoy, R. K. (1996). Symptom assessment. Hematology Oncology Clinics of North America, 10, 21–39.
Chang, V., Hwang, S., Feuerman, M., & Kasimis, B. S. (2000). Symptom and quality of life surveys of medical oncology patients at a Veterans Affairs Medical Center: A role for symptom assessment. Cancer, 88, 1175–1183.
Acknowledgment
This study was supported by an unrestricted grant from AstraZeneca Pharmaceuticals.
Author information
Authors and Affiliations
Corresponding author
Additional information
Athanassios Argiris—Formerly of Feinberg School of Medicine, Northwestern University, Chicago, IL.
Appendix: Functional Assessment of Cancer Therapy Head and Neck Symptom Index
Appendix: Functional Assessment of Cancer Therapy Head and Neck Symptom Index
Below is a list of statements that other people with your illness have said are important. By circling one number per line, please indicate how true each statement has been for you during the past 7 days
Not at all | A little bit | Some-what | Quite a bit | Very much | ||
---|---|---|---|---|---|---|
GP4 | I have pain | 0 | 1 | 2 | 3 | 4 |
GP1 | I have a lack of energy | 0 | 1 | 2 | 3 | 4 |
H & N7 | I can swallow naturally and easily | 0 | 1 | 2 | 3 | 4 |
H & N 12 | I have pain in my mouth, throat, or neck | 0 | 1 | 2 | 3 | 4 |
H & N3 | I have trouble breathing | 0 | 1 | 2 | 3 | 4 |
H & N10 | I am able to communicate with others | 0 | 1 | 2 | 3 | 4 |
GP2 | I have nausea | 0 | 1 | 2 | 3 | 4 |
H & N11 | I can eat solid foods | 0 | 1 | 2 | 3 | 4 |
GE6 | I worry that my condition will get worse | 0 | 1 | 2 | 3 | 4 |
GF7 | I am content with the quality of my life right now | 0 | 1 | 2 | 3 | 4 |
Rights and permissions
About this article
Cite this article
Yount, S., List, M., Du, H. et al. A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores. Qual Life Res 16, 1615–1626 (2007). https://doi.org/10.1007/s11136-007-9270-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-007-9270-9